Find your next paid study

SarcomaGastrointestinal Cancer

~$10 – $1,125

Actual pay is set by the research site.

Daily NouriNCT07831317

Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies

This prospective, single-institution, observational study explores disease outcomes and toxicities in subjects with gastrointestinal malignancies and sarcoma (…

UNC Lineberger Comprehensive Cancer CenterNCT05743426

Actual pay is set by the research site.

Peritoneal CarcinomatosisGastrointestinal Peritoneal Carcinomatosis

Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis

This is a pilot study gathering and using samples and data from patients with gastrointestinal peritoneal carcinomatosis. Participants will be asked for permis…

University of California, IrvineNCT05844865

Actual pay is set by the research site.

Association of Presenting Symptoms and Diagnosis, With Urinary Mycotoxins, Metals, Polyfluorinated Alkyl Substance (PFAS) and Environmental Toxins - A Prospective Study in an Urban Gastroenterology Practice

The goal of this observational study is to evaluate the levels of urinary environmental toxins, heavy metals, PFAS and mycotoxins with gastrointestinal (GI) an…

Gastrointestinal Diseases

Vibrant America Clinical LabNCT06278311

Actual pay is set by the research site.

Cystic Fibrosis (CF)Cystic Fibrosis Gastrointestinal Disease

Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet

There is no study to date that has evaluated the impact or effect of a Mediterranean diet in children with CF. The goal of this study would be to help provide …

Dartmouth-Hitchcock Medical CenterNCT07223255

Actual pay is set by the research site.

Helicobacter Pylori InfectionHelicobacter PyloriHelicobacter Pylori Gastrointestinal Tract Infection+2 more

H. Pylori Eradication With Argon Plasma During Endoscopy (HEAPE)

The objective of the study is to investigate the efficacy and safety of an argon plasma-based therapy - HEAPE - in treating H. pylori infections during endosco…

Christopher C. Thompson, MD, MScNCT06529159

~$10 – $1,125

Actual pay is set by the research site.

Phase 2

Dose-response of Aerobic Training During Chemotherapy for Gastrointestinal Cancers

The purpose of this study is to find the level of aerobic exercise (AT) that is practical, is safe, and has positive effects on the body that may reduce the si…

Gastrointestinal Cancer

Memorial Sloan Kettering Cancer CenterNCT05789485

~$75 – $2,000

Actual pay is set by the research site.

Gastrointestinal Neoplasm

Prospective Single Centre, Post Market, Randomized Controlled Trial to Demonstrate Feasibility, Safety and Efficacy, of a Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection

The goal of this prospective, single centre, 1:1, Post Market, randomized controlled, Investigator Initiated trial, is to compare the feasibility, safety effic…

Baylor College of MedicineNCT06134687

Actual pay is set by the research site.

Somatostatin Receptor PositiveGastrointestinal Neuroendocrine TumorsPheochromocytoma+1 more

Phase I/II Trial of Systemic Targeted Radioligand Therapy (TRT) With Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR Positive (SSTR+) Gastrointestinal (GI) Neuroendocrine Tumors (NET) and Pheochromocytoma/Paragangliomas Previously Treated With Systemic Radioligand Therapy

Background: Gastrointestinal neuroendocrine tumors (GI NET) are a type of cancer that affects the stomach and intestines; pheochromocytoma/paragangliomas (PPG…

National Cancer Institute (NCI)NCT06427798

~$150 – $2,700

Actual pay is set by the research site.

Gastric CancerGastrointestinal CancerHER2 Gene Mutation

A Multi-Center Phase I Trial of Neratinib and Fam-trastuzumab Deruxtecan in Advanced Refractory Gastric and Esophageal Cancer Patients

This is Phase 1 dose finding trial with potential dose expansion to evaluate the safety, toxicity, recommended phase 2 dose (RP2D), and maximum tolerated dose …

Fox Chase Cancer CenterNCT05274048

~$150 – $3,000

Actual pay is set by the research site.

Gastrointestinal Stromal Tumor (GIST)

A Master Protocol for the Multi-cohort, Open-label, Phase 1/2 Study of DCC-3009 in Participants With Gastrointestinal Stromal Tumor (GIST)

The purpose of this Phase 1/2 master protocol study is to evaluate if DCC-3009 is safe, tolerable and works effectively in the treatment of GIST. The study wil…

Deciphera Pharmaceuticals, LLCNCT06630234

~$150 – $4,200

Actual pay is set by the research site.

Gastrointestinal Stromal Tumor (GIST)Gastrointestinal Stromal CancerGastrointestinal Stromal Neoplasm+2 more

A Phase 1a/1b Study of the Safety, Pharmacokinetics, and Antitumor Activity of the Oral Menin Inhibitor Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) After Imatinib Failure

In this clinical trial, the safety, tolerability, and preliminary antitumor activity of ziftomenib in combination with imatinib will be evaluated in adults wit…